Ristocetin A sulfate is a potent antibacterial glycopeptide antibiotic that was withdrawn from clinical use following a high incidence of thrombocytopenia. Further investigation found that ristocetin A induced platelet aggregation by binding to a factor absent in people suffering from von Willebrand's disease, leading to the use of ristocetin A as an important diagnostic aid.
Ristocetin A sulfate is soluble in ethanol, methanol, DMF and DMSO.
Ristocetin A sulfate is soluble in ethanol, methanol, DMF and DMSO.
